Please login to the form below
pediatrics
This page shows the latest pediatrics news and features for those working in and with pharma, biotech and healthcare.
Dr Reddy's brings its generics portfolio to France
Meanwhile, in its home country it is targeting a number of therapy areas, having agreed a 118m deal with UCB in 2015 to acquire a portfolio of dermatology, respiratory and pediatric
Latest news
-
Lilly pilots enhanced online trial information
The pilot project has so far been added to two clinical trials, a study of Taltz (ixekizumab) in non-radiographic axial spondyloarthritis and one of Cialis (tadalafil) in pediatric patients with
-
Biogen buys into Ionis' nusinersen after positive phase III trial
Potential blockbuster spinal muscular atrophy drug will be filed “in the coming months”
-
Celebrating excellence
The programme saw Novo work in partnership with Roche, the International Society for Pediatric and Adolescent Diabetes (ISPAD) and the World Diabetes Foundation (WDF).
-
PMEA 2015 win for Novo's Changing Diabetes in Children
The programme saw Novo work in partnership with Roche, the International Society for Pediatric and Adolsecent Diabetes (ISPAD) and the World Diabetes Foundation (WDF).
-
Novartis gets FDA nod for rare blood disorder drug
James Bussel, a professor of pediatrics, of pediatrics in obstetrics and gynecology and of pediatrics in medicine at Weill Cornell Medical College, and lead study investigator, added: “ Young patients with chronic
More from news
Approximately 1 fully matching, plus 22 partially matching documents found.
Latest Intelligence
-
Implementing eHealth innovation
The first results from the global, five-year observational study in children with growth disorders was presented at the 10th International Meeting of Pediatric Endocrinology in September 2017.
-
Paging Dr Millennial
Almost 50% of the world's population today is under 25 years old, which means that family planning, women's health and pediatrics will be growing elements of the world's
-
Pharma deals in August 2015
In 2012 the PRV programme was extended to include rare pediatric diseases and the emergence of trading in PRVs was noted in our last annual Deal Watch report.
-
Pharma deals during November 2014
In 2012 the PRV programme was extended to include rare pediatric diseases. ... BioMarin was awarded a Rare Pediatric Disease PRV when it received approval of Vimizim, a new biological product for patients with Mucopolysaccharidosis type IVA.
-
Pharma deals during March 2013
825. Edison Pharmaceuticals/ Dainippon Sumitomo. Licence. EPI-743 (orphan pediatric mitochondrial disease) and EPI-589 (adult CNS disease) (phase II).
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest appointments
-
BMS appoints oncology development head
As a trained pediatric oncologist, Fouad brings to this role exceptional clinical experience and an unwavering commitment to patients. “
-
Dr Andrew Mulberg moves from FDA to Amicus Therapeutics
Dr Mulberg is a pediatric gastroenterologist, and was attending physician and fellowship director in gastroenterology and hepatology for The Children's Hospital of Philadelphia between 1993 and 2001. ... He is currently the board chairman and member of
-
Former PEPFAR head Mark Dybul to lead the Global Fund
In addition to his new post, Dr Dybul currently serves as a director on several executive and advisory boards of health organisations, including Malaria No More, the Elizabeth Glaser Pediatric AIDS
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Featured jobs
- Editor – Medical Education Agency – Bucks
-
Salary TBC
- Senior Account Director, Healthcare Brand Communications, London
-
Excellent Package
-
Senior Medical Writer
-
Great salary and bebefits
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
- Project Manager, Medical Communications, Oxford
-
Excellent Salary
- Account Manager – Med Comms – London
-
Salary TBC
-
Senior Programme Executive
-
Salary TBC
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
-
Scientific Director
-
Great salary and bebefits
- Group Account Director, Healthcare Brand Communications, London
-
Excellent Package
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
- Medical Writer, e-learning/ training, London
-
Excellent Salary
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
- Head of Operations/ BUD, Healthcare PR, London – Excellent leade...
-
Excellent Package
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
- Project Manager, Medical Communications, London
-
Excellent Salary
- FREELANCE Account Manager – Creative Healthcare Advertising – Lo...
-
SUPERB DAY RATES AVAILABLE
-
Senior Medical Writer
-
Great salary and benefits
Subscribe to our email news alerts
- P&G agrees $4.2bn buy of Merck KGaA’s consumer health unit
- Publicis LifeBrands Team win UK young Cannes Lions competition
- Sobi poaches Pfizer’s Fredrick Wetterlundh
- Rigel and Ultragenyx claim approvals for rare drugs
- VCCP Health strengthens client service team
- Is agile working benefiting the employee or the organisation?
PMHub
M3 (EU)
M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...
Latest intelligence
- The threat of antimicrobial resistance
- Why this issue is such a fundamental challenge...
- Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
- Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
- Unique forum will unite NHS and industry to drive innovation
- HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...
Quick links
Infographics
